| Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa MW Carroll, DA Matthews, JA Hiscox, MJ Elmore, G Pollakis, A Rambaut, ... Nature 524 (7563), 97-101, 2015 | 370 | 2015 |
| The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs C Martin, A Williams, R Hernandez-Pando, PJ Cardona, E Gormley, ... Vaccine 24 (17), 3408-3419, 2006 | 309 | 2006 |
| Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials A Arbues, JI Aguilo, J Gonzalo-Asensio, D Marinova, S Uranga, ... Vaccine 31 (42), 4867-4873, 2013 | 295 | 2013 |
| Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs A Williams, R Reljic, I Naylor, SO Clark, G Falero‐Diaz, M Singh, ... Immunology 111 (3), 328-333, 2004 | 221 | 2004 |
| Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis A Williams, GJ Hatch, SO Clark, KE Gooch, KA Hatch, GA Hall, K Huygen, ... Tuberculosis 85 (1-2), 29-38, 2005 | 208 | 2005 |
| Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases NF Walker, SO Clark, T Oni, N Andreu, L Tezera, S Singh, L Saraiva, ... American journal of respiratory and critical care medicine 185 (9), 989-997, 2012 | 171 | 2012 |
| Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing SA Sharpe, H McShane, MJ Dennis, RJ Basaraba, F Gleeson, G Hall, ... Clinical and Vaccine Immunology 17 (8), 1170-1182, 2010 | 148 | 2010 |
| Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: protection associated with mycobacterial antigen-specific CD4 … S Sharpe, A White, C Sarfas, L Sibley, F Gleeson, A McIntyre, R Basaraba, ... Tuberculosis 101, 174-190, 2016 | 135 | 2016 |
| Boosting with Poxviruses Enhances Mycobacterium bovis BCG Efficacy against Tuberculosis in Guinea Pigs A Williams, NP Goonetilleke, H McShane, SO Clark, G Hatch, SC Gilbert, ... Infection and immunity 73 (6), 3814-3816, 2005 | 122 | 2005 |
| Animal models of tuberculosis: Guinea pigs S Clark, Y Hall, A Williams Cold Spring Harbor perspectives in medicine 5 (5), a018572, 2015 | 117 | 2015 |
| Enhanced Protection against Tuberculosis by Vaccination with Recombinant Mycobacterium microti Vaccine That Induces T Cell Immunity against Region of … P Brodin, L Majlessi, R Brosch, D Smith, G Bancroft, S Clark, A Williams, ... The Journal of infectious diseases 190 (1), 115-122, 2004 | 97 | 2004 |
| Intranasal IFNγ extends passive IgA antibody protection of mice against Mycobacterium tuberculosis lung infection R Reljic, SO Clark, A Williams, G Falero-Diaz, M Singh, S Challacombe, ... Clinical & Experimental Immunology 143 (3), 467-473, 2006 | 87 | 2006 |
| Non-Replicating Mycobacterium tuberculosis Elicits a Reduced Infectivity Profile with Corresponding Modifications to the Cell Wall and Extracellular Matrix J Bacon, LJ Alderwick, JA Allnutt, E Gabasova, R Watson, KA Hatch, ... PloS one 9 (2), e87329, 2014 | 81 | 2014 |
| Determination of lesion volume by MRI and stereology in a macaque model of tuberculosis SA Sharpe, E Eschelbach, RJ Basaraba, F Gleeson, GA Hall, A McIntyre, ... Tuberculosis 89 (6), 405-416, 2009 | 81 | 2009 |
| Ultra low dose aerosol challenge with Mycobacterium tuberculosis leads to divergent outcomes in rhesus and cynomolgus macaques S Sharpe, A White, F Gleeson, A McIntyre, D Smyth, S Clark, C Sarfas, ... Tuberculosis 96, 1-12, 2016 | 74 | 2016 |
| Evaluation of the immunogenicity of Mycobacterium bovis BCG delivered by aerosol to the lungs of macaques AD White, C Sarfas, K West, LS Sibley, AS Wareham, S Clark, MJ Dennis, ... Clinical and Vaccine Immunology 22 (9), 992-1003, 2015 | 71 | 2015 |
| Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system D Bottai, W Frigui, S Clark, E Rayner, A Zelmer, N Andreu, MI de Jonge, ... Vaccine 33 (23), 2710-2718, 2015 | 67 | 2015 |
| Protective efficacy of a lipid antigen vaccine in a guinea pig model of tuberculosis G Larrouy-Maumus, E Layre, S Clark, J Prandi, E Rayner, M Lepore, ... Vaccine 35 (10), 1395-1402, 2017 | 60 | 2017 |
| Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate … E Badell, F Nicolle, S Clark, L Majlessi, F Boudou, A Martino, ... Vaccine 27 (1), 28-37, 2009 | 60 | 2009 |
| Persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus and viral RNA in relation to surface type and contamination concentration S Paton, A Spencer, I Garratt, KA Thompson, I Dinesh, P Aranega-Bou, ... Applied and Environmental Microbiology 87 (14), e00526-21, 2021 | 59 | 2021 |
